LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer-Reference-Cited by-同舟云学术

LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer

Published:2013-12-14 Issue:4 Volume:5 Page:970-977
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lovat Francesca¹,Ishii Hideshi²,Schiappacassi Monica³,Fassan Matteo¹⁴,Barbareschi Mattia⁵,Galligioni Enzo⁵,Gasparini Pierluigi¹,Baldassarre Gustavo³,Croce Carlo M.¹,Vecchione Andrea¹⁶

Affiliation:

1. Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University Wexner Medical Center and Comprehensive Cancer Center, Columbus, Ohio, USA

2. Department of Frontier Science for Cancer and Chemotherapy Osaka University, Japan

3. Division of Experimental Oncology 2, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy

4. ARC-NET Research Centre, University and Hospital Trust of Verona, Verona, Italy

5. Departments of Pathology and Medical Oncology, Ospedale Santa Chiara, Trento, Italy

6. University of Rome “La Sapienza”, Department of Clinical and Molecular Medicine, Ospedale Santo Andrea, Rome, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-04-19

2. Chromosome 8;Cancer Genes;2023-07-09

3. Reduced sister chromatid cohesion acts as a tumor penetrance modifier;PLOS Genetics;2022-08-22

4. Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer;Pathology - Research and Practice;2022-06

5. Application of an open-chamber multi-channel microfluidic device to test chemotherapy drugs;Scientific Reports;2020-11-23